445312-14-1

Basic information

• Product Name: N-[(1S,4R)-4-{(1R,3aS,7aR)-4-[2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-1-(1-methyl-1-trimethylsilanyloxy-ethyl)-pentyl]-benzamide
• CAS NO: 445312-14-1
• Molecular Weight: 706.213
• Mol File: 445312-14-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[(1S,4R)-4-{(1R,3aS,7aR)-4-[2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-1-(1-methyl-1-trimethylsilanyloxy-ethyl)-pentyl]-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(1S,4R)-4-{(1R,3aS,7aR)-4-[2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-1-(1-methyl-1-trimethylsilanyloxy-ethyl)-pentyl]-benzamide(445312-14-1)
• EPA Substance Registry System: N-[(1S,4R)-4-{(1R,3aS,7aR)-4-[2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-1-(1-methyl-1-trimethylsilanyloxy-ethyl)-pentyl]-benzamide(445312-14-1)

Safety Data

• Hazardous Substances Data: 445312-14-1(Hazardous Substances Data)

Upstream product

• 100858-27-3 (S)-(Z)-{2-[5-(tert-butyldimethylsiloxy)-2-methylenecyclohexylidene]ethyl}diphenylphosphine oxide 
• 445312-13-0 N-[(1S,4R)-4-((1R,3aR,7aR)-7a-Methyl-4-oxo-octahydro-inden-1-yl)-1-(1-methyl-1-trimethylsilanyloxy-ethyl)-pentyl]-benzamide 
• 445312-12-9 N-[(1S,4R)-1-(1-Hydroxy-1-methyl-ethyl)-4-((1R,3aR,7aR)-7a-methyl-4-oxo-octahydro-inden-1-yl)-pentyl]-benzamide 
• 445312-11-8 N-[(1S,4R)-1-(1-Hydroxy-1-methyl-ethyl)-4-((1R,3aR,4S,7aR)-4-hydroxy-7a-methyl-octahydro-inden-1-yl)-pentyl]-benzamide 

Relevant articles and documents

Synthesis of the First 24-Aminovitamin D3 Derivatives by Diastereoselective Conjugate Addition to a Chiral Methyleneoxazolidinone in Aqueous Media

The synthesis of the first 24-aminovitamin D3 derivatives is reported. A stereoselective convergent synthetic approach was employed to prepare 24(S)-benzoylamino-25-hydroxyvitamin D3 and 24(S)-benzoylamino-1α,25-dihydroxyvitamin Dsu